Trade Ideas: BIO, TNC, ASHW, FVL, SMMX, BRY, CEO, ACO
BIO: Small hammer at the 20-day MA. Significant resistance at $68. Prior congestion around $63 should provide support. Point-n-figure target of $89 only for the patient. Short term traders more likely to benefit with a sale at $68.
TNC: Upside break of trading consolidation. Follow through price target of $63. Support at 50-day MA best place for support. Resistance at $55 a concern. Point-n-figure target of $74.
ASHW: Sideways consolidation followed with an upside breakout. Four day consolidation in the upper range of last weeks heavier volume buying provides a low risk opportunity with a stop on a loss of $10.10. Point-n-figure chart still shows the stock has plenty of work to do.
FVL: Tight action between $17.00-$17.25. 50-day MA below to provide support. Cautionary bearish divergence in money flow. Slow burner; unlikely to reap dividends for short term traders.
SMMX: Initial break of $29.50 was rejected but stock has held above $28.50 support. Slight increase in buying volume favors another bullish attack. Weekly chart holds to a bullish ascending triangle. Projected target of $42 which closely approximates the point-n-figure target of $43.
BRY: Mixed bag. The last 4-days of advance have the look of a bear flag which may mean a test of the 50-day MA. Weekly chart shows good prior support at the 40-week average (currently at $64.86). Point-n-figure target of $107 not outside the realms of possiblity given its steady advance from $40.37.
CEO: Bounce off the 50-day MA but remains vulnerable as the break of $88 resistance was rejected. The bullish cross of the 20-day/50-day MA looks to be fueling the current buying. Ride the 20-day MA up.
ACO: Plenty of heavy volume volatility. 50-day MA holds as support (stops can go just below). Point-n-figure target of $60.50 looks ambitious at this juncture. Look for a projected move to $41.

Trade Ideas
If you would like to try a full version of the Trade-Ideas software, follow this link for a free 7-day trial.








0 Comments:
Post a Comment
<< Home